Danaher Corp (DHR)
Danaher designs, manufactures and markets medical, industrial and commercial products and services. Co.'s segments are: Biotechnology, which includes the bioprocessing and discovery and medical businesses and provides tools, consumables and services; Life Sciences, which provides instruments and consumables to understand the causes of disease, identify new therapies, and test and manufacture new drugs, vaccines and gene editing technologies; Diagnostics, which provides clinical instruments, reagents, consumables, software and services; and Environmental and Applied Solutions, which provides products and services that help protect resources and keep global food and water supplies safe.
Danaher SEC Filing Email Alerts Service
Preferreds: DHR.PRA, DHR.PRB
Company Name: |
Danaher Corp |
Website: |
www.danaher.com |
Sector: |
Biotechnology |
Number of ETFs Holding DHR: |
97 |
Total Market Value Held by ETFs: |
$20.02B |
Total Market Capitalization: |
$182.87B |
% of Market Cap. Held by ETFs: |
10.95% |
|
|
May 6, 2024 10:15 AM Eastern
Buy (3.26 out of 4)
43rd percentile
|
|